Health
Harvard Scientists Trial siRNA Therapy for Prion Diseases
Harvard University researchers have begun human trials of an siRNA therapy aimed at reducing the prion protein behind Creutzfeldt-Jakob disease.
Bringing you stories that vibe with your fashion